Dexketoprofen and Ibuprofen in Long Bone Fractures
Launched by ANKARA CITY HOSPITAL BILKENT · Sep 28, 2023
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two pain relief medications, dexketoprofen and ibuprofen, to see which one works better for patients with long bone fractures, such as breaks in the tibia (shin bone), femur (thigh bone), or humerus (upper arm bone). The trial is currently looking for participants, and anyone aged between 18 and 80 who has a significant fracture and is experiencing moderate to severe pain may qualify. To be eligible, participants should be conscious, cooperative, and able to communicate their pain level.
If you decide to take part in this study, you will receive one of the two medications to help manage your pain. The researchers want to understand how effective each medication is, so your experience and feedback will be important. It’s also worth noting that certain conditions, like having other serious health issues or being pregnant, may prevent you from participating. This study is a great opportunity to contribute to medical knowledge while receiving care for your injury.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • over 18 years
- • Patients under 80 years of age
- • Patients who agreed to participate in the study
- • One of the tibia, femur and humerus bones is broken
- • Patients with a VAS score of 50 and above
- • Patients with no other injuries requiring emergency surgery
- • Previously known adverse reactions to the active ingredient of the drugs to be used patients with no history
- • Conscious patients
- • Oriented cooperative patients
- Exclusion Criteria:
- • Patients under the age of 18 and over the age of 80
- • Patients who did not agree to participate in the study
- • Patients with vital signs outside the normal limits
- • Patients with a history of adverse reactions to known NSAIDs
- • Those who cannot determine the severity of pain on the VAS
- • Patients with a VAS Score of 50 mm or less
- • Those with other orthopedic injuries pregnant women
- • Those with advanced systemic disease
- • Those with malignancy
- • Those with chronic liver and kidney disease
- • Those who use neuro-psychiatric drugs with sedative and analgesic effects
- • Those with a history of psychological and neurological diseases
- • Patients using analgesics 8 hours before the examination
About Ankara City Hospital Bilkent
Ankara City Hospital Bilkent is a leading healthcare institution in Turkey, dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. Equipped with state-of-the-art facilities and a multidisciplinary team of experienced professionals, the hospital fosters a collaborative environment for conducting rigorous scientific investigations. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the highest level of integrity, ultimately contributing to the development of new therapies and enhancing the quality of care provided to patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Safa Dönmez, MD
Principal Investigator
Ankara City Hospital Bilkent
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported